924 material Form 8-K filings that 737 companies we cover made with the SEC in January 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tetra Tech reported first-quarter fiscal 2026 revenue of $1.21 billion and net revenue of $1.04 billion, with EPS of $0.40 against $0.00 a year earlier, when a $115 million legal contingency charge weighed on results. The company raised its fiscal 2026 net revenue and adjusted EPS guidance and declared a $0.065 per share quarterly dividend, up 12% year over year, so shareholders see a higher outlook alongside lower reported revenue.
Q1 revenue was $1.21 billion versus $1.42 billion a year earlier; net revenue was $1.04 billion versus $1.20 billion.
Q1 EPS was $0.40 versus $0.00 a year earlier; adjusted EPS was $0.35, unchanged from the prior year.
FY2026 net revenue guidance was raised to $4.15 billion to $4.30 billion, and adjusted EPS guidance to $1.46 to $1.56.
Quarterly dividend of $0.065 per share is payable February 27, 2026, to holders of record on February 12, 2026; Q1 share repurchases totaled $50 million.
Adtalem Global Education (NYSE: ATGE) reported second quarter fiscal 2026 revenue of $503.4 million, up 12.4%, and raised its fiscal 2026 adjusted earnings per share guidance to $7.80 to $8.00, while keeping its revenue guidance unchanged. The results include $18.0 million of incremental Walden revenue from a shifted academic week, and Chamberlain's operating income fell 24.2%, so shareholders may weigh the strength of the headline growth against those factors. Note: this 8-K was filed by Adtalem Global Education Inc., not Covista Inc. (CVSA) as the request stated.
Q2 fiscal 2026 revenue $503.4 million, up 12.4% year-over-year; diluted EPS $2.11 vs. $1.98; adjusted EPS $2.43 vs. $1.81, up 34.3%
Fiscal 2026 adjusted EPS guidance raised to $7.80 to $8.00 from $7.60 to $7.90; revenue guidance maintained at $1,900 million to $1,940 million
Chamberlain Q2 operating income $32.0 million vs. $42.2 million a year earlier, down 24.2%; Walden operating income rose 53.8% to $75.2 million
New $750 million share repurchase program through December 2028; $165 million of shares repurchased in Q2
Brinker reported second-quarter fiscal 2026 results that improved from a year earlier, with total revenues of $1,452.2 million and net income of $128.5 million. The company raised its full-year fiscal 2026 guidance for total revenues and non-GAAP earnings per diluted share, citing a stronger outlook for Chili's, though Winter Storm Fern reduced results by an estimated $20.0 million in revenue and $0.15 per diluted share.
Diluted EPS was $2.86 versus $2.61 a year earlier; excluding special items, non-GAAP EPS was $2.87 versus $2.80.
Full-year fiscal 2026 total revenue guidance was raised to $5.76 billion-$5.83 billion from $5.60 billion-$5.70 billion.
Full-year non-GAAP EPS guidance was raised to $10.45-$10.85 from $9.90-$10.50.
Company comparable restaurant sales rose 7.5%, with Chili's up 8.6% and Maggiano's down 2.4%; the company repurchased $100.0 million of its stock during the quarter.
ADP reported fiscal second-quarter 2026 results for the quarter ended December 31, 2025, with revenue up 6% and net earnings up 10%, and raised its full-year fiscal 2026 outlook for revenue growth and adjusted diluted EPS growth. For shareholders, the quarter showed growth in both revenue and profit, and the updated guidance signals management's expectations for the rest of the year.
Revenue rose 6% to $5.4 billion; net earnings rose 10% to $1.1 billion
Diluted EPS rose 11% to $2.62; adjusted diluted EPS also rose 11% to $2.62
Fiscal 2026 revenue growth outlook is now about 6%, up from 5% to 6%
Adjusted diluted EPS growth outlook is now 9% to 10%, up from 8% to 10%
Halozyme raised its 2026 financial guidance on January 28, 2026, with total revenue now expected at $1,710 million to $1,810 million, up from $1,430 million to $1,530 million. The company also gave preliminary, unaudited 2025 total revenue of $1,385 million to $1,400 million and disclosed its acquisition of Surf Bio, which carries up to $400 million in total consideration.
2026 royalty revenue guidance raised to $1,130 million-$1,170 million from $900 million-$940 million
2026 non-GAAP diluted EPS guidance raised to $7.75-$8.25 from $6.50-$7.00, including about $60 million of Hypercon and Surf Bio investment not in prior guidance
Surf Bio acquired for an upfront payment of $300 million, plus up to $100 million in milestone payments
Preliminary 2025 royalty revenue estimated at $865 million-$870 million, with 51% to 52% year-over-year growth
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.